The stock of HCA Healthcare Inc (HCA) has seen a -1.97% decrease in the past week, with a 3.05% gain in the past month, and a 19.51% flourish in the past quarter. The volatility ratio for the week is 1.70%, and the volatility levels for the past 30 days are at 1.56% for HCA. The simple moving average for the last 20 days is -0.62% for HCA stock, with a simple moving average of 17.41% for the last 200 days.
Is It Worth Investing in HCA Healthcare Inc (NYSE: HCA) Right Now?
The price-to-earnings ratio for HCA Healthcare Inc (NYSE: HCA) is 17.13x, which is above its average ratio. Moreover, the 36-month beta value for HCA is 1.67. Analysts have varying opinions on the stock, with 10 analysts rating it as a “buy,” 6 as “overweight,” 6 as “hold,” and 0 as “sell.”
The public float for HCA is 191.47M and currently, short sellers hold a 1.56% of that float. On April 05, 2024, HCA’s average trading volume was 1.08M shares.
HCA) stock’s latest price update
HCA Healthcare Inc (NYSE: HCA)’s stock price has decreased by -2.12 compared to its previous closing price of 332.20. However, the company has seen a -1.97% decrease in its stock price over the last five trading sessions. InvestorPlace reported 2024-04-03 that The recent uptick in U.S. manufacturing signals a promising trend for the economy. Investor confidence in the economy’s stability is reflected in the decreasing odds for a June rate cut, indicating optimism about future monetary policy.
Analysts’ Opinion of HCA
Many brokerage firms have already submitted their reports for HCA stocks, with Barclays repeating the rating for HCA by listing it as a “Overweight.” The predicted price for HCA in the upcoming period, according to Barclays is $356 based on the research report published on March 06, 2024 of the current year 2024.
Bernstein, on the other hand, stated in their research note that they expect to see HCA reach a price target of $301, previously predicting the price at $277. The rating they have provided for HCA stocks is “Mkt Perform” according to the report published on January 04th, 2024.
Goldman gave a rating of “Neutral” to HCA, setting the target price at $271 in the report published on December 11th of the previous year.
HCA Trading at 3.50% from the 50-Day Moving Average
After a stumble in the market that brought HCA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -2.79% of loss for the given period.
Volatility was left at 1.56%, however, over the last 30 days, the volatility rate increased by 1.70%, as shares surge +0.55% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +14.13% upper at present.
During the last 5 trading sessions, HCA fell by -1.97%, which changed the moving average for the period of 200-days by +12.10% in comparison to the 20-day moving average, which settled at $327.29. In addition, HCA Healthcare Inc saw 20.13% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at HCA starting from Wasserman Chad J, who sale 876 shares at the price of $330.25 back on Mar 20 ’24. After this action, Wasserman Chad J now owns 1,576 shares of HCA Healthcare Inc, valued at $289,299 using the latest closing price.
Wasserman Chad J, the SVP and CIO of HCA Healthcare Inc, sale 344 shares at $321.97 during a trade that took place back on Mar 18 ’24, which means that Wasserman Chad J is holding 2,452 shares at $110,758 based on the most recent closing price.
Stock Fundamentals for HCA
Current profitability levels for the company are sitting at:
- 0.15 for the present operating margin
- 0.85 for the gross margin
The net margin for HCA Healthcare Inc stands at 0.08. The total capital return value is set at 0.22.
Based on HCA Healthcare Inc (HCA), the company’s capital structure generated 1.05 points at debt to capital in total, while cash flow to debt ratio is standing at 0.24. The debt to equity ratio resting at -22.22. The interest coverage ratio of the stock is 4.96.
Currently, EBITDA for the company is 12.73 billion with net debt to EBITDA at 3.22. When we switch over and look at the enterprise to sales, we see a ratio of 1.95. The receivables turnover for the company is 6.52for trailing twelve months and the total asset turnover is 1.16. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.18.
Conclusion
To wrap up, the performance of HCA Healthcare Inc (HCA) has been better in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
